Forward focussed thinking

Blue Latitude Health’s consultancy is based on a rich vein of expert knowledge. Here you’ll find thought-provoking commentary, articles, and downloadable resources created by our consultants.

Explore our ideas and get a deeper understanding of the current and future trends in healthcare:

genomic-data-visualised-creative-commons-image-blue-latitude-health

What pharma needs to know about genomic data in 2016

David Cooney | 3rd February 2016

About ten years ago, personalised medicine was a major step forward – tailoring treatments based on individual patient history and information. Fast forward to 2015, and investigating the central dogma of biology is still a major focus of healthcare research. 

Consultant David Cooney talks us through what this progress in genomics means for pharma in 2016.

read more

content-strategy-maturing-your-approach-blue-latitude-health-wine-stock-image

Content Strategy for pharma: Maturing your approach in 2016

Liz Inskip | 26th January 2016

The way that many pharma and healthcare brands think about content strategy – the creation, management, storage, and governance of content – hasn’t matured in quite the same way as multichannel marketing strategy.

In this article, Consultant Adwoa Baah and Content Marketing Manager Liz Inskip take us through three things pharma can do to improve content strategy maturity within their organisations in 2016.

read more

blue-latitude-health-paper-balls-on-coral-background-time-to-rethink-insight

Should we rethink ‘insight’ in healthcare?

Martine Leroy | 20th January 2016

Like other sectors, healthcare relies on insight. Therefore, it isn’t immune to the factors that affect the likelihood of a business to reach meaningful insight.

Head of Insight Martine Leroy explains why it's time to rethink what 'insight' means in healthcare.

read more

surfing-healthcare-disruption-tsunami-blue-latitude-health

How to surf the healthcare disruption tsunami

James Atherton | 12th January 2016

Moving into 2016, we want to draw the focus to the issue of tangibly defining value in healthcare innovation and ensuring that the services that pharma and healthcare brands are developing are actually taken up and implemented. Managing Consultant James Atherton talks through some tangible tips for businesses and brands looking to surf the wave of disruption in 2016.

read more

globes-map-wood-table-photograph

Regional campaigns: Improving local uptake while staying on-message

Dolan Desai | 22nd October 2015

Localising global and regional campaigns is a challenge all global organisations face. However, for healthcare brands, it can be even more challenging because local regulations and systems can be so variable and complicated. Account Director Dolan Desai talks us through five core considerations that will allow you to maximise impact across a region through coherent execution.

read more

insight-lens-camera-focus-path

10 tips for developing insightful pre-launch positioning

Martine Leroy | 8th October 2015

By getting your positioning right, you can build the motivational, aspirational, and resonant brand story and messaging that will allow your product to become a brand. Head of Insight Martine Leroy delivers her top tips on how to keep insight at the centre of your positioning to best support your brand.

read more

sketchnote-blue-latitude-health-portfolio-planning

Bigger than brand: Portfolio positioning for pharma

Jenna Earl | 29th September 2015

With pharma in the midst of a patent cliff, portfolios of treatments are becoming more and more common, and the need for a clear co-positioning strategy has never been greater.

Senior Consultant Jenna Earl talks us through the three most important things to understand about portfolio positioning in pharma.

read more

clinic-medical-scientist-medicine-lab

Tackling biosimilars – how to handle the threat to pharma brands

Mark Assenti | 23rd September 2015

Recently, Blue Latitude Health worked with a global pharmaceutical brand to develop a strategy for dealing with the introduction of biosimilars to the market. Their product, a treatment in the gastroenterology therapy area, had recently come off patent and a biosimilar was about to launch. Strategy Consultant Mark Assenti talks through three key points for developing a strategy to tackle biosimilars.

read more

patient-centricity-elisa-del-galdo-blue-latitude-health

Patient-centricity: Navigating away from the centre

Elisa del Galdo | 15th September 2015

Traditionally, we look at the environment of the patient with the patient in the centre of a circle of healthcare professionals, carers, institutions or clinics, and sometimes services. Elisa del Galdo takes us through a better way to look at patient-centricity: with the patient’s journey at the centre.

read more

one-way-road-sign-sepia-tone-photo

How to nail pre-launch positioning in pharma

Matt Bolton | 22nd July 2015

Recently, we’ve worked across multiple brands in oncology on launch and pre-launch strategy, which raises a unique set of challenges in a competitive and highly regulated market. Matt Bolton, Head of Commercial, takes us through the three key points to keep in mind when developing a pharmaceutical pre-launch positioning strategy.

read more